参考文献/References:
[1]Krasovskiǐ GN,Dergacheva TS,Egorova NA,et al.Obosnovanie predelńo dopustimoǐ kontsentratsii arbidola i tiofenola v vode vodnykh obektov [Rationale for maximum permissible concentration of arbidole and thiophenol in water reservoirs][J].Gig Sanit,1994(1):7-8.[2]吕菁君,赵光举,赵宏宇,等.成人流行性感冒诊疗规范急诊专家共识(2022版)[J].中国急救医学,2022,42(12):1013-1026.[3]陈龙,余修祥,李旻,等.抗病毒药物甲磺酸阿比朵尔的合成[J].武汉工程大学学报,2012,34(8):42-45.[4]Glushkov G,Fadeena I,Lenenva A,et al.Molecular biological characteristics of the action of Arbidol--a new antiviral drug[J].Pharmaceutical Chemistry Journal,1992,26(2):106-115.[5]Leneva A,Fadeena I,Fedykina T.The study of the effect of a new antiviral drug arbido on different stages of viral reproduction[J].Antiviral Research,1994,23(7):S135.[6]Villalaín J.Membranotropic effects of arbidol, a broad anti-viral molecule, on phospholipid model membranes[J].J Phys Chem B,2010,114(25):8544-8554.[7]Sumiov P,Karpovva A,Skulish H.The Immuniomodulating properties of Arbidol[J].Pharmaceutical Chemistry Journal,1995,29(3):165-166.[8]Galiano V,Villalaín J.The Location of the Protonated and Unprotonated Forms of Arbidol in the Membrane: A Molecular Dynamics Study[J].J Membr Biol,2016,249(3):381-391.[9]Brooks MJ,Burtseva EI,Ellery PJ,et al.Antiviral activity of arbidol, a broad-spectrum drug for use against respiratory viruses, varies according to test conditions[J].J Med Virol,2012,84(1):170-181.[10]孙颖光,张淑慧,邱志宏,等.阿比朵尔胶囊在健康人体内的药动学(英文)[J].中国新药与临床杂志,2008(3):161-164.[11]刘晓,陈晓辉,刘文涛,等.阿比朵尔人血浆蛋白结合率的测定[J].中国新药与临床杂志,2007(2):115-119.[12]Deng P,Zhong D,Yu K,et al.Pharmacokinetics, metabolism, and excretion of the antiviral drug arbidol in humans[J].Antimicrob Agents Chemother,2013,57(4):1743-1755.[13]宋丽洁,封宇飞,李可欣,等.盐酸阿比朵尔颗粒剂、干混悬剂与胶囊剂在健康人体的相对生物利用度[J].中国临床药理学杂志,2007(4):292-295.[14]封宇飞,吕俊玲,宋丽洁,等.盐酸阿比朵尔胶囊剂、片剂在中国健康人体药动学和相对生物利用度[J].中国药学杂志,2008(16):1257-1260.[15]Liu MY,Wang S,Yao WF,et al.Pharmacokinetic properties and bioequivalence of two formulations of arbidol: an open-label, single-dose, randomized-sequence, two-period crossover study in healthy Chinese male volunteers[J].Clin Ther,2009,31(4):784-792.[16]申劲锋,马序竹,姜楠,等.盐酸阿比朵尔胶囊在中国成年健康受试者的生物等效性研究[J].中国临床药理学杂志,2016,32(24):2266-2268.[17]Nasser ZH,Swaminathan K,Müller P,et al.Inhibition of influenza hemagglutinin with the antiviral inhibitor arbidol using a proteomics based approach and mass spectrometry[J].Antiviral Res,2013,100(2):399-406.[18]张兴权,代军朋,蔡柏蔷.盐酸阿比朵尔体外抑制2009新型流感病毒A(H1N1)的作用[J].中国医学科学院学报,2012,34(2):126-129.[19]邓杨梅,张水娟,陈季强,等.可用于SARS治疗的抗病毒药物[J].世界临床药物,2005(1):11-15,20.[20]纪晓光,赵艳红,张敏,等.阿比多尔抗SARS病毒的体外实验研究[J].解放军药学学报,2004(4):274-276.[21]Assiri A,Al-Tawfiq JA,Al-Rabeeah AA,et al.Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study[J].Lancet Infect Dis,2013,13(9):752-761.[22]关文达,杜秋伶,江海明,等.阿比多尔与连花清瘟胶囊对中东呼吸综合征冠状病毒的体内外抑制作用比较[J].广东医学,2018,39(23):3454-3458.[23]Dinesh DC,Tamilarasan S,Rajaram K,et al.Antiviral Drug Targets of Single-Stranded RNA Viruses Causing Chronic Human Diseases[J].Curr Drug Targets,2020,21(2):105-124.[24]Hulseberg CE,Fénéant L,Szymańska-de Wijs KM,et al.Arbidol and Other Low-Molecular-Weight Drugs That Inhibit Lassa and Ebola Viruses[J].J Virol,2019,93(8):e02185-18.[25]国家药品监督管理局.国家药品不良反应监测年度报告(2020年)[EB/OL].(2021-03-26)[2023-04-15].https//www.nmpa.gov.cn/xxgk/fgwj/gzwj/gzwjyp/20210325170127199.html.[26]张明,杨星辰,金丽,等.122例中药制剂所致ADR特点及其影响因素[J].中成药,2021,43(8):2268-2271.[27]何俊明,徐闪.我院病区中药注射剂不合理使用情况分析与管理建议[J].中医药管理杂志,2021,29(6):68-69.[28]全国人民代表大会.中华人民共和国医师法[EB/OL].(2021-08-20)[2023-03-17].http://www.npc.gov.cn/npc/c2/c30834/202108/t20210820_313104.html.[29]王卫国,鄢思佳,古津贤.美国超说明书用药对我国启示的伦理思考[J].中国医学伦理学,2018,31(7):886-889.[30]广东省药学会.超药品说明书用药中患者知情同意权的保护专家共识[J].今日药学,2019,29(6):361-367.